# Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea

> **NCT05509868** · PHASE3 · COMPLETED · sponsor: **Pharmbio Korea Co., Ltd.** · enrollment: 182 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** PBK_L1704 0.35mg
- **DRUG:** PBK_L1704 0.5mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05509868
- **Lead sponsor:** Pharmbio Korea Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-25
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05509868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05509868, "Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05509868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*